RE:RE:Raymond James - cantechletter.comPersonally if I'm interested in a stock , I like to hear what people are saying.
I don't NECESSARILY have to agree with it; that's where your due diligence comes in.
For example , cantechletter.com had an article the other day for the new HEALWELL AI (AIDX), the old MCI which Well Health controls with comments by an Eight Capital analyst.
"“HEALWELL is a unique growth opportunity at the intersection of healthcare and AI, offering scarcity value in the public markets,” the analyst argued. “The company’s mission is preventative care, leveraging technology to identify at-risk patients and drive better healthcare outcomes. With material financial
and strategic alignment with WELL Health (WELL-T, BUY, C$10.00 TP), we believe HEALWELL is in the early innings of a data-driven land-grab strategy in healthtech.”
Technically the comment is true as in it's unique with their strategic alignment with Well HEalth but I can think of at least one other company that shares that scarcity value.
In favour of reading everything and then practicing , trust and verify.
GLTA